Article: FDA Approves ADDERALL XR(R) to Treat ADHD in Adults.

ADDERALL XR Is First Stimulant Medication Approved for Attention Deficit Hyperactivity Disorder in Adults

Shire Pharmaceuticals Group plc announced today that the U.S. Food and Drug Administration (FDA) has approved ADDERALL XR(R) (mixed salts of a single-entity amphetamine) as a once daily treatment for adults with Attention Deficit Hyperactivity Disorder (ADHD). Since 2001, ADDERALL XR has been approved in the U.S. for the treatment of ADHD in children.

Up to 65 percent of children with ADHD may still exhibit symptoms into adulthood and an estimated 4.4 percent of the U.S. adult populations are affected by ADHD. If left untreated, this disorder may ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!